Results 221 to 230 of about 1,715,615 (239)

Prostate cancer in BRCA2 germline mutation carriers is associated with poorer prognosis

British Journal of Cancer, 2010
P Osin, D P Dearnaley, Z Kóte-Jarai
exaly  

BRCA1 and BRCA2 mutations correlate with TP53 abnormalities and presence of immune cell infiltrates in ovarian high-grade serous carcinoma

Modern Pathology, 2012
Katy Milne, Jessica N McAlpine, Sohrab P. Shah   +2 more
exaly  

Clinical and pathologic findings of prophylactic salpingo-oophorectomies in 159 BRCA1 and BRCA2 carriers

Gynecologic Oncology, 2006
Steven A. Narod, Terence Colgan, Amy Finch   +2 more
exaly  

Outcome of BRCA1- compared with BRCA2-associated ovarian cancer: a nationwide study in the Netherlands

Annals of Oncology, 2013
Marjanka K Schmidt, Geertruida H. de Bock, H F A Vasen   +2 more
exaly  

BRCA2 is a moderate penetrance gene contributing to young-onset prostate cancer: implications for genetic testing in prostate cancer patients

British Journal of Cancer, 2011
Elena Castro, Rosalind Eeles, D Goldgar
exaly  

Genetic Screens Reveal FEN1 and APEX2 as BRCA2 Synthetic Lethal Targets

Molecular Cell, 2019
Alan D'Andrea, Stephen Elledge, Richard Adeyemi   +2 more
exaly  

Rapid progression of prostate cancer in men with a BRCA2 mutation

British Journal of Cancer, 2008
Steven A. Narod, William David Foulkes, Peter J Ainsworth   +2 more
exaly  

Structural basis for recruitment of BRCA2 by PALB2

EMBO Reports, 2009
Antony W. Oliver, Christopher J Lord, Laurence Pearl   +2 more
exaly  

A glycolytic metabolite bypasses “two-hit” tumor suppression by BRCA2

Cell
Joan Choo, David Perera, C Pawan K Patro
exaly  

BRCA2 regulates DMC1-mediated recombination through the BRC repeats

Proceedings of the National Academy of Sciences of the United States of America, 2016
Aura Carreira, Åsa Ehlén, Alexander Mazin   +2 more
exaly